Skip to content

Morfologie en functie van de hypothalamus na glucose inname door proefpersonen voor en na het gebruik van een hoogcalorisch dieet gedurende vijf dagen.

Hypothalamic neuronal activity in response to glucose ingestion after temporary overfeeding healthy young men.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21031
Enrollment
10
Registered
2009-03-27
Start date
2009-02-28
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes type 2 suikerziekte ouderdomssuikerziekte diabetes

Interventions

High caloric diet during 6 days.

Sponsors

Prof. dr. H. Pijl, internist-endocrinoloog
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy males; 2. Healthy diet; 3. Age 19-29; 4. BMI 19-25 kg/m2; 5. Stable weight for the last 2 years; 6. Caucasian; 7. FPG 7.5 mmol/l; 9. No family history of DM2.

Exclusion criteria

Exclusion criteria: 1. Use of medication known to affect glucose metabolism (for example prednisone) or lipid metabolism; 2. History of genetic or psychiatric disease (e.g. fragile X syndrome, major depression) that affects the brain; 3. Significant chronic disease; 4. Renal or hepatic disease; 5. Recent weight changes or attempts to loose or gain weight (> 3 kg weight gain or loss, within the last 3 months); 6. Smoking (current); 7. Alcohol consumption of more than 28 units per week at present or in the past; 8. Recent blood donation (within the last 3 months); 9. Recent participation in other research projects (within the last 3 months); 10. Participation in 2 or more projects in one year; 11. Sleep disorders; 12. Contra-indication to MRI scanning: A. Claustrophobia; B. Pacemakers and defibrillators; C. Nerve stimulators; D. Intracranial clips; E. Intraorbital or intraocular metallic fragments; F. Cochlear implants; E. Ferromagnetic implants.

Design outcomes

Primary

MeasureTime frame
1. FMRI scans of hypothalamus; 2. Polysomnography/MSLT.

Secondary

MeasureTime frame
1. Metabolomics; 2. Inflammatory markers; 3. Oral glucose tolerance test; 4. Gut hormones.

Contacts

Public ContactM.A. Wijngaarden
m.a.wijngaarden@lumc.nl+31715265304

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)